Fortis Healthcare Limited (FORTIS)
The relevant disclosure is attached
Press Release - Q1FY27
- Consolidated revenue 255.95bn (+18%) y-y; EBITDA 55.16bn; PAT 27.28bn
- Healthcare segment revenue 218.67bn, diagnostics 40.65bn for Q1FY27
- Exceptional gain of 953m includes reversal of impairment on associate
- Board approved standalone and consolidated unaudited Q1FY27 results
- Ongoing SFIO and SEBI investigations relate to pre-2018 transactions; provisions made
- Board approved grant of 130.87m ESOPs under 2026 scheme
- Final dividend Rs 1.00/share recommended for FY26, subject to AGM approval
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 FORTIS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add FORTIS to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Fortis Healthcare Limited
Important.
The summary above is generated automatically from Fortis Healthcare Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.